Skip to main content
Übersichtsarbeit

Kognitive Verzerrungen und Metakognition bei Multipler Sklerose (MS)

Published Online:https://doi.org/10.1024/1016-264X/a000214

Zusammenfassung. Neben einer Reihe physischer Beeinträchtigungen sind die psychischen und kognitiven Störungen bei Multipler Sklerose (MS) seit einigen Jahren im Fokus von Patienten und Behandlern. Funktionale und kompensatorische Therapieansätze konnten bisher jedoch nur bescheidene rehabilitative Erfolge vorweisen. Der Umgang mit diesen Beeinträchtigungen und die Bewältigung der damit einhergehenden Herausforderungen erscheinen gut für kognitiv-behaviorale Therapieansätze geeignet. Vor diesem Hintergrund wurde das Metakognitive und alltagsrelevante Training für Patienten mit Multipler Sklerose (MaTiMS) mit einem Fokus auf spezifische kognitive und psychische Beeinträchtigungen bei MS entwickelt und adressiert mithilfe eines metakognitiven Ansatzes zugrunde liegende kognitive Verzerrungen. Weitere vergleichbare therapeutische Entwicklungen für MS-Patienten gibt es bisher keine. Diese Übersichtsarbeit soll einen Überblick über typische kognitive Verzerrungen bei MS und deren Behandlung geben.


Cognitive biases and metacognition in Multiple Sclerosis (MS)

Abstract. The psychological and cognitive impairments from multiple sclerosis (MS) have been in the focus of both patients and physicians for several years now. However, existing functional and compensatory treatment approaches have yielded only modest benefits. It has been hypothesized that patients might benefit from cognitive behavioral therapy approaches. The Metacognitive and Allday life-relevant Training in MS patients (MaTiMS) was developed with a focus toward addressing the specific cognitive and psychological difficulties found in MS as well as underlying cognitive biases through a metacognitive approach. To date, no comparable therapeutic developments exist for MS patients. This review provides an overview of typical cognitive biases in MS and their treatment.

Literatur

  • Amato, M. P. & Zipoli, V. (2008). Cognitive changes in multiple sclerosis. Expert Review of Neurotherapeutics, 8(10), 1585–1596. First citation in articleCrossrefGoogle Scholar

  • Arnett, P. A., Barwick, F. H. & Beeney, J. E. (2008). Depression in multiple sclerosis: review and theoretical proposal. Journal of the International Neuropsychological Society, 14(5), 691–724. First citation in articleCrossrefGoogle Scholar

  • Arnett, P. A., Higginson, C. I., Voss, W. D., Randolph, J. J. & Grandey, A. A. (2002). Relationship Between Coping, Cognitive Dysfunction and Depression in Multiple Sclerosis. Clinical Neuropsychologist, 16(3), 341–355. First citation in articleCrossrefGoogle Scholar

  • Artemiadis, A. K., Anagnostouli, M. C. & Alexopoulos, E. C. (2011). Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology, 36(2), 109–120. First citation in articleCrossrefGoogle Scholar

  • Beeney, J. & Arnett, P. A. (2008). Stress and memory bias interact to predict depression in multiple sclerosis. Neuropsychology, 22(1), 118–126. First citation in articleCrossrefGoogle Scholar

  • Berzins, S. A., Bulloch, A. G., Burton, J. M., Dobson, K. S., Fick, G. H. & Patten, S. B. (2017). Determinants and incidence of depression in multiple sclerosis: A prospective cohort study. Journal of Psychosomatic Research, 99, 169–176. First citation in articleCrossrefGoogle Scholar

  • Bora, E., Özakbaş, S., Velakoulis, D. & Walterfang, M. (2016). Social Cognition in Multiple Sclerosis: a Meta-Analysis. Neuropsychology Review, 26(2), 160–172. First citation in articleCrossrefGoogle Scholar

  • Brissart, H., Leroy, M., Morele, E., Baumann, C., Spitz, E. & Debouverie, M. (2013). Cognitive rehabilitation in Multiple sclerosis, Neurocase, 19(6), 553–565. First citation in articleCrossrefGoogle Scholar

  • Bruce, J. M. & Arnett, P. A. (2005). MS patients with depressive symptoms exhibit affective memory biases when verbal encoding strategies are suppressed. Journal of the International Neuropsychological Society: JINS, 11(5), 514–521. First citation in articleGoogle Scholar

  • Bruce, J. M., Polen, D. & Arnett, P. A. (2007). Pain and affective memory biases interact to predict depressive symptoms in multiple sclerosis. Multiple Sclerosis Journal, 13(1), 58–66. First citation in articleCrossrefGoogle Scholar

  • Calandri, E., Graziano, F., Borghi, M. & Bonino, S. (2017). Coping strategies and adjustment to multiple sclerosis among recently diagnosed patients: the mediating role of sense of coherence. Clinical Rehabilitation, 31(10), 1386–1395. First citation in articleCrossrefGoogle Scholar

  • Carver, C. S., Scheier, M. F. & Weintraub, J. K. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56(2), 267–283 First citation in articleCrossrefGoogle Scholar

  • Chiaravalloti, N. D. & DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. Lancet. Neurology, 7(12), 1139–1151. First citation in articleCrossrefGoogle Scholar

  • Cotter, J., Firth, J., Enzinger, C., Kontopantelis, E., Yung, A. R. & Elliott, R. et al. (2016). Social cognition in multiple sclerosis: A systematic review and meta-analysis. Neurology, 87(16), 1727–1736. First citation in articleCrossrefGoogle Scholar

  • D’Zurilla, T. J. & Nezu, A. M. (1999). Problem Solving Therapy. A Social Competence Approach to Clinical Intervention (2nd ed.). New York: Springer. First citation in articleGoogle Scholar

  • das Nair, R., Ferguson, H., Stark, D. L. & Lincoln, N. B. (2012). Memory Rehabilitation for people with multiple sclerosis. Cochrane Database of Systematic Reviews, 3. doi: 10.1002/14651858.CD008754.pub2 First citation in articleGoogle Scholar

  • Einarsson, U., Gottberg, K., Fredrikson, S., von Koch, L. & Holmqvist, L. W. (2006). Activities of daily living and social activities in people with multiple sclerosis in Stockholm County. Clinical Rehabilitation, 20(6), 543–551. First citation in articleCrossrefGoogle Scholar

  • Fassbender, K., Schmidt, R., Mössner, R., Kischka, U., Kühnen, J. & Schwartz, A. et al. (1998). Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Archives of Neurology, 55(1), 66–72. First citation in articleCrossrefGoogle Scholar

  • Fiest, K. M., Dykeman, J., Patten, S. B., Maxwell, C. J. & Bulloch, A. G. M. (2013). Depression in epilepsy: A systematic review and meta-analysis. Neurology, 80(6), 590–599. First citation in articleCrossrefGoogle Scholar

  • Flavell, J. H. (1971). First discussant’s comments. What is memory development the development of? Human Development, 14, 272–278. First citation in articleCrossrefGoogle Scholar

  • Flavell, J. H. & Wellman, H. M. (1977). Metamemory. In J. W.Hagen (Ed.), Perspectives on the Development of Memory and Cognition (pp. 3–33). HiIIsdale, NJ: Erlbaum. First citation in articleGoogle Scholar

  • Gaweda, L., Moritz, S. & Kokoszka, A. (2009). The metacognitive training for schizophrenia patients: description of method and experiences from clinical practice. Psychiatria Polska, 43(6), 683–692. First citation in articleGoogle Scholar

  • Goverover, Y., Chiaravalloti, N. D., Genova, H. & DeLuca, J. (2017). A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial. Multiple Sclerosis Journal. doi: 10.1177/1352458517709955 First citation in articleGoogle Scholar

  • Goverover, Y., Chiaravalloti, N. D., O’Brien, A. R. & DeLuca, J. (2017). Evidenced-Based Cognitive Rehabilitation for Persons With Multiple Sclerosis: An Updated Review of the Literature From 2007 to 2016. Archives of Physical Medicine and Rehabilitation. doi: 10.1016/j.apmr.2017.07.021 First citation in articleGoogle Scholar

  • He, D., Zhang, Y., Dong, S., Wang, D., Gao, X. & Zhou, H. (2013). Pharmacological treatment for memory disorder in multiple sclerosis. Cochrane Database of Systematic Reviews, 12. doi: 10.1002/14651858.CD008876.pub3 First citation in articleGoogle Scholar

  • Heesen, C., Stückrath, E., Köpke, S., Hauptmann, B. & Henze, T. (2010). Rehabilitation bei Multipler Sklerose in Deutschland – Ergebnisse einer Umfrage. Rehabilitation in Multiple Sclerosis in Germany – Results of a Survey, Aktuelle Neurologie, 37(1), 4–9. First citation in articleCrossrefGoogle Scholar

  • Heidenreich, T., Michalak, J. & Eifert, G. (2007). Achtsamkeit, Akzep- tanz und die dritte Welle der Verhaltenstherapie. Psychotherapie, Psychosomatik, Medizinische Psychologie, 57(12), 475–486. First citation in articleCrossrefGoogle Scholar

  • Henneghan, A., Stuifbergen, A., Becker, H., Kullberg, V. & Gloris, N. (2017). Perceived Cognitive Deficits in a Sample of Persons Living With Multiple Sclerosis. Journal of Neuroscience Nursing, 49(5), 274–279. First citation in articleCrossrefGoogle Scholar

  • Howard, J., Trevick, S. & Younger, D. S. (2016). Epidemiology of Multiple Sclerosis. Neurologic Clinics, 34(4), 919–939. First citation in articleCrossrefGoogle Scholar

  • Janardhan, V. & Bakshi, R. (2002). Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of the Neurological Sciences, 205(1), 51–58. First citation in articleCrossrefGoogle Scholar

  • Johnen, A., Landmeyer, N. C., Bürkner, P.-C., Wiendl, H., Meuth, S. G. & Holling, H. (2017). Distinct cognitive impairments in different disease courses of multiple sclerosis – A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 83, 568–578. First citation in articleCrossrefGoogle Scholar

  • Jopson, N. M. & Moss-Morris, R. (2003). The role of illness severity and illness representations in adjusting to multiple sclerosis. Journal of Psychosomatic Research, 54(6), 503–511. First citation in articleCrossrefGoogle Scholar

  • Kinsinger, S. W., Lattie, E. & Mohr, D. C. (2010). Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology, 24(5), 573–580. First citation in articleCrossrefGoogle Scholar

  • Koch, M. W., Glazenborg, A., Uyttenboogaart, M., Mostert, J. & De Keyser, J. (2011). Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database of Systematic Reviews, 2. doi: 10.1002/14651858.CD007295.pub2 First citation in articleGoogle Scholar

  • Krupp, L. B. (2003). Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs, 17(4), 225–234. First citation in articleCrossrefGoogle Scholar

  • Krupp, L. B., Serafin, D. J. & Christodoulou, C. (2010). Multiple sclerosis-associated fatigue. Expert Review of Neurotherapeutics, 10(9), 1437–1447. First citation in articleCrossrefGoogle Scholar

  • Kurt, A., Nijboer, F., Matuz, T. & Kübler, A. (2007). Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs, 21(4), 279–291. First citation in articleCrossrefGoogle Scholar

  • Mäntynen, A., Rosti-Otajärvi, E., Koivisto, K., Lilja, A., Huhtala, H. & Hämäläinen, P. (2013) Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomized controlled multi-centre trial. Multiple Sclerosis Journal, 20(1), 99–107. First citation in articleGoogle Scholar

  • Miller, P. & Soundy, A. (2017). The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis. Journal of the Neurological Sciences, 381, 41–54. First citation in articleCrossrefGoogle Scholar

  • Mitchell, A. J., Benito-Leon, J., Gonzalez, J. M. & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet. Neurology, 4(9), 556–566. First citation in articleCrossrefGoogle Scholar

  • Mohr, D., Hart, S., Julian, L., Cox, D. & Pelletier, D. (2004). Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. British Medical Journal, 328(7442), 731. First citation in articleGoogle Scholar

  • Moritz, S., Schröder, J., Meyer, B. & Hauschildt, M. (2013). The more it is needed, the less it is wanted: attitudes toward face-to-face intervention among depressed patients undergoing online treatment. Depression and Anxiety, 30(2), 157–167. First citation in articleCrossrefGoogle Scholar

  • Moritz, S. & Woodward, T. S. (2007). Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Current Opinion in Psychiatry, 20(6), 619–625. First citation in articleCrossrefGoogle Scholar

  • Motl, R. W., Balto, J. M., Ensari, I. & Hubbard, E. A. (2017). Self-efficacy and Walking Performance in Persons With Multiple Sclerosis. Journal of Neurologic Physical Therapy, 41(2), 114–118. First citation in articleCrossrefGoogle Scholar

  • O’Brien, A., Gaudino-Goering, E., Shawaryn, M., Komaroff, E., Moore, N. B. & DeLuca, J. (2007). Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists, 22(8), 933–948. First citation in articleGoogle Scholar

  • Patejdl, R., Penner, I. K., Noack, T. K. & Zettl, U. K. (2016). Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmunity Reviews, 15(3), 210–220. First citation in articleCrossrefGoogle Scholar

  • Ploughman, M., Collins, K., Wallack, E. M., Monks, M., Mayo, N. & Fisk, J. D. et al. (2017). Women’s and men’s differing experiences of health, lifestyle, and aging with multiple sclerosis. International Journal of MS Care, 19(4), 165–171. First citation in articleCrossrefGoogle Scholar

  • Pöttgen, J., Lau, S., Penner, I., Heesen, C. & Moritz, S. (2015). Managing Neuropsychological Impairment in Multiple Sclerosis. International Journal of MS Care, 17(3), 130–137. First citation in articleGoogle Scholar

  • Pöttgen, J., Stephan, J., Gold, S. M., Heesen, C. & Penner, I.-K. (2015). Perceived and objective attentional deficits in multiple sclerosis. Zeitschrift für Neuropsychologie, 26, 171–178. First citation in articleGoogle Scholar

  • Rosti-Otajärvi, E. M. & Hämäläinen, P. I. (2011). Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database of Systematic Reviews, 11. doi: 10.1002/14651858.CD009131.pub3 First citation in articleGoogle Scholar

  • Rosti-Otajärvi, E. M. & Hämäläinen, P. I. (2014). Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database of Systematic Reviews, 2. doi: 10.1002/14651858.CD009131.pub3 First citation in articleGoogle Scholar

  • Schwartz, C. E., Coulthard-Morris, L., Zeng, Q. & Retzlaff, P. (1996). Measuring self-efficacy in people with multiple sclerosis: a validation study. Archives of Physical Medicine and Rehabilitation, 77(4), 394–398. First citation in articleCrossrefGoogle Scholar

  • Shevil, E. & Finlayson, M. (2010). Pilot study of a cognitive intervention program for persons with multiple sclerosis. Health Education Research, 25(1), 41–53. First citation in articleCrossrefGoogle Scholar

  • Skerrett, T. N. & Moss-Morris, R. (2006). Fatigue and social impairment in multiple sclerosis: The role of patients’ cognitive and behavioral responses to their symptoms. Journal of Psychosomatic Research, 61(5), 587–593. First citation in articleCrossrefGoogle Scholar

  • Solaro, C., Bergamaschi, R., Rezzani, C., Mueller, M., Trabucco, E. & Bargiggia, V. et al. (2013). Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients. Clinical Neuropharmacology, 36(4), 114–116. First citation in articleCrossrefGoogle Scholar

  • Strober, L. B., Binder, A., Nikelshpur, O. M., Chiaravalloti, N. & DeLuca, J. (2016). The perceived deficits questionnaire: Perception, deficit, or distress? International Journal of MS Care, 18(4), 183–190. First citation in articleCrossrefGoogle Scholar

  • Stuifbergen, A. K., Becker, H., Perez, F., Morison, J., Kullberg, V. & Todd, A. (2012). A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis. Clinical Rehabilitation, 26(10), 882–893. First citation in articleCrossrefGoogle Scholar

  • Ukueberuwa, D. M. & Arnett, P. A. (2014). Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis. Journal of the International Neuropsychological Society, 20(7), 751–755. First citation in articleCrossrefGoogle Scholar

  • van Kessel, K. & Moss-Morris, R. (2006). Understanding multiple sclerosis fatigue: A synthesis of biological and psychological factors. Journal of Psychosomatic Research, 61(5), 583–585. First citation in articleCrossrefGoogle Scholar

  • Vercoulen, J. H. M. M., Hommes, O. R., Swanink, C. M. A., Jongen, P. J. H., Fennis, J. F. M. & Galama, J. M. D. et al. (1996). The Measurement of Fatigue in Patients With Multiple Sclerosis. Archives of Neurology, 53(7), 642. First citation in articleGoogle Scholar

  • Wineman, N. M., Schwetz, K. M., Zeller, R. & Cyphert, J. (2003). Longitudinal analysis of illness uncertainty, coping, hopefulness, and mood during participation in a clinical drug trial. Journal of Neuroscience Nursing: Journal of the American Association of Neuroscience Nurses, 35(2), 100–106. First citation in articleCrossrefGoogle Scholar